My understanding is that their clinical trial is testing the drug in combination with the Standard of Care drug "Mycophenolate Mofetil" . When I researched this later drug, it appears that in 3 years or so, the market for "Mofetil" is expected to reach $125 Million, Have you read anywhere that Auph believes Voclosporin can address a bigger market (indication)?
"The market for this lupus complication is very large and if this drug is approved we could easily be looking at a 10 bagger within the next couple of years...you might want to look into it."